Iris Loew-Friedrich

Iris Loew-Friedrich serves as the Supervisory Board Chairperson and a member of the Supervisory Board at Evotec since June 2014, and as a member of the Supervisory Board at Fresenius Group since May 2016. Additionally, Iris is a board member at TransCelerate BioPharma Inc. and PhRMA Foundation. An Adjunct Professor for Internal Medicine at Goethe-Universität Frankfurt a. Main since 2000, Iris held the position of Executive Vice President, Head of Development & Chief Medical Officer at UCB until September 2024. Former leadership roles include Head of Research and Development at Schwarz Pharma AG, Vice President at BASF Pharma overseeing global projects, and Vice President of Global Clinical Management at Aventis/Hoechst Marion Roussel. Iris holds a Doctor of Medicine (MD) from Goethe University Frankfurt and a PhD in Biophysics from the Max Planck Institute for Physics.